Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for urgent unmet medical needs. Our current focus is on the treatment of patients with pancreatic cancer. The initial product candidate is SBP-101, a polyamine metabolic inhibitor in clinical development for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Panbela Therapeutics, Inc. is a clini...
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for urgent unmet medical needs. Our current focus is on the treatment of patients with pancreatic cancer. The initial product candidate is SBP-101, a polyamine metabolic inhibitor in clinical development for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Panbela Therapeutics, Inc. is a clinical stage drug development company. The Company's initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.